Literature DB >> 10915110

Molecular stool screening for colorectal cancer. Using DNA markers may be beneficial, but large scale evaluation is needed.

D A Ahlquist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10915110      PMCID： PMC1118258          DOI： 10.1136/bmj.321.7256.254

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  Morphometric analysis of the "mucocellular layer" overlying colorectal cancer and normal mucosa: relevance to exfoliation and stool screening.

Authors:  D A Ahlquist; J J Harrington; L J Burgart; P C Roche
Journal:  Hum Pathol       Date:  2000-01       Impact factor: 3.466

Review 2.  Fecal occult blood testing for colorectal cancer. Can we afford to do this?

Authors:  D A Ahlquist
Journal:  Gastroenterol Clin North Am       Date:  1997-03       Impact factor: 3.806

3.  Mutations of the p53 gene in the stool of patients with resectable colorectal cancer.

Authors:  S Eguchi; N Kohara; K Komuta; T Kanematsu
Journal:  Cancer       Date:  1996-04-15       Impact factor: 6.860

4.  Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel.

Authors:  D A Ahlquist; J E Skoletsky; K A Boynton; J J Harrington; D W Mahoney; W E Pierceall; S N Thibodeau; A P Shuber
Journal:  Gastroenterology       Date:  2000-11       Impact factor: 22.682

5.  Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors.

Authors:  D Sidransky; T Tokino; S R Hamilton; K W Kinzler; B Levin; P Frost; B Vogelstein
Journal:  Science       Date:  1992-04-03       Impact factor: 47.728

6.  Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer.

Authors:  A Loktionov; I K O'Neill; K R Silvester; J H Cummings; S J Middleton; R Miller
Journal:  Clin Cancer Res       Date:  1998-02       Impact factor: 12.531

7.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.

Authors:  J D Hardcastle; J O Chamberlain; M H Robinson; S M Moss; S S Amar; T W Balfour; P D James; C M Mangham
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

8.  Randomised study of screening for colorectal cancer with faecal-occult-blood test.

Authors:  O Kronborg; C Fenger; J Olsen; O D Jørgensen; O Søndergaard
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

Review 9.  Genetic instability and chromosomal aberrations in colorectal cancer: a review of the current models.

Authors:  C R Boland; J Sato; K Saito; J M Carethers; G Marra; L Laghi; D P Chauhan
Journal:  Cancer Detect Prev       Date:  1998

10.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

Authors:  J S Mandel; J H Bond; T R Church; D C Snover; G M Bradley; L M Schuman; F Ederer
Journal:  N Engl J Med       Date:  1993-05-13       Impact factor: 91.245
View more
  7 in total

1.  Can DNA sampling from the rectal mucosa be a novel tool for the detection of colorectal cancer?

Authors:  Ulrik Wallin; Ulf Gunnarsson; Bengt Glimelius; Alexandre Loktionov; Lars Påhlman
Journal:  Int J Colorectal Dis       Date:  2010-06-19       Impact factor: 2.571

Review 2.  Oncogenomic Changes in Pancreatic Cancer and Their Detection in Stool.

Authors:  Heidelinde Sammallahti; Virinder Kaur Sarhadi; Arto Kokkola; Reza Ghanbari; Sama Rezasoltani; Hamid Asadzadeh Aghdaei; Pauli Puolakkainen; Sakari Knuutila
Journal:  Biomolecules       Date:  2022-04-29

3.  Stool DNA and occult blood testing for screen detection of colorectal neoplasia.

Authors:  David A Ahlquist; Daniel J Sargent; Charles L Loprinzi; Theodore R Levin; Douglas K Rex; Dennis J Ahnen; Kandice Knigge; M Peter Lance; Lawrence J Burgart; Stanley R Hamilton; James E Allison; Michael J Lawson; Mary E Devens; Jonathan J Harrington; Shauna L Hillman
Journal:  Ann Intern Med       Date:  2008-10-07       Impact factor: 25.391

4.  Molecular events in primary and metastatic colorectal carcinoma: a review.

Authors:  Rani Kanthan; Jenna-Lynn Senger; Selliah Chandra Kanthan
Journal:  Patholog Res Int       Date:  2012-05-09

5.  Tests detecting biomarkers for screening of colorectal cancer: What is on the horizon?

Authors:  Angaja Phalguni; Helen Seaman; Kristina Routh; Stephen Halloran; Sue Simpson
Journal:  GMS Health Technol Assess       Date:  2015-06-10

6.  Fecal molecular markers for colorectal cancer screening.

Authors:  Rani Kanthan; Jenna-Lynn Senger; Selliah Chandra Kanthan
Journal:  Gastroenterol Res Pract       Date:  2011-11-17       Impact factor: 2.260

7.  Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design.

Authors:  Nea Malila; Tiina Oivanen; Outi Malminiemi; Matti Hakama
Journal:  BMJ       Date:  2008-11-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.